Track record · closed signal

Innoviva Inc (INVA) — closed signal from June 5, 2026

Partial Published before the outcome was known, scored automatically when the window closed on September 3, 2026 — -6.7% at the close.

Predicted vs. what happened

INVA price · publication thesis → realized outcomesplit-adjusted
$22.88 Published $28.60 Target $21.35 Window close $24.17 Peak
$21.80 – $23.20Entry zone — fair-value band
$22.88Published — price the day we called it
$28.60Target — the price the thesis aimed for
$24.17Peak — highest point inside the window, not a realized return
$21.35Window close — end-of-window price, context only

What happened

Partial

Reached 22% of the predicted growth at its peak, without hitting the target.

At window close
-6.7%
realized, from the publication price to the last close inside the window
Peak gain
+5.6%
peak, from the publication price — not a realized return
S&P 500, same window
+5.1%
SPY over the identical days, dividend-adjusted
Window close
$21.35
last close inside the window, ended September 3, 2026
Peak price
$24.17
peak on June 24, 2026 — not a realized return
Days to target
—

The thesis — published June 5, 2026

Predicted growth
+25%
over the measurement window
Target price
$28.60
the price the thesis aimed for
Entry zone
$21.80 – $23.20
the fair-value band we waited for
Price at publication
$22.88
published June 5, 2026
Confidence
77%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Innoviva combines steady royalty cash with a small portfolio of medical products. Good valuation and a strong balance sheet make the stock less risky than many small companies. Upcoming conference appearances, a recent institutional purchase, and positive royalty notes have renewed interest. Momentum is not yet clear; better trading participation would strengthen the short-term upside case.

Primary drivers

  • Royalties provide steady cash that helps cover risks
  • Therapeutics portfolio could add meaningful future sales
  • Investor events can bring fresh attention to the stock
  • Institutional buying signals renewed professional interest

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All INVA signals